Dr. Mimi Lin, MD

Dr. Lin practices at Golden Gate Endoscopy Center in San Francisco, California.

Dr. Lin's NPI, 1659588457, was assigned on May 17, 2007. Dr. Lin graduated from Albert Einstein College of Medicine in 2002. Dr. Lin's California license number on file is 810040.

Dr. Lin's primary practice is Golden Gate Endoscopy Center, at 3370 Geary Boulevard, First Floor, San Francisco, CA 94118. The practice phone is (415) 379-7500.

Dr. Lin's primary practice is Golden Gate Endoscopy Center in San Francisco, California. Dr. Lin is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lin to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lin is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lin has a license on file in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Lin treats.

CMS data shows 802 Medicare services from Dr. Lin across 19 procedure codes in 2024, for 298 Medicare patients. Medicare paid $80,787 for them.

CMS counts 298 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 58, with 61% women.

In 2024, Dr. Lin wrote 631 Medicare Part D claims for 230 patients. 68% of them were for generic drugs. CMS names the drug for 519 of them, across 17 drugs with 11 or more claims each, at $117,349 in total drug cost. In 2023, CMS named 653 claims across 23 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 199 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lin, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Lin in 2016. Dr. Lin's most frequent co-authors are Nikhil Agarwal, MD and William John Snape, MD.

CMS Open Payments shows 339 general payments to Dr. Lin from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Allergan Inc. paid the most, $28,906.

Dmand AI lists 1 award for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from Albert Einstein College of Medicine in 2002. Dr. Lin is a member of ACG and AGA.

Dr. Lin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.